What is GBS?
GBS (Group B Streptococcus, scientific name: Streptococcus agalactiae) is a common bacterium that typically colonizes the intestines and lower genital tract (such as the vagina and rectum) of healthy adults. While GBS is generally harmless to healthy adults, it is a leading cause of serious infections in newborns.
Significance of GBS Screening
GBS (Group B Streptococcus) screening is crucial for pregnant women in their late third trimester (35-37 weeks). Its core significance is to identify mothers who carry GBS and administer intravenous antibiotics during labor. This effectively prevents the baby from contracting a severe GBS infection during birth.
Newborn GBS infection can lead to fatal pneumonia, sepsis, or meningitis. Through screening and preventive treatment, the risk of early-onset GBS disease in newborns can be reduced by over 80%. It is a simple, highly effective, and essential prenatal test for safeguarding the health of both mother and baby.
Why do we use Group B Streptococcus Detection Kit?
1.Fast speed meets urgent clinical needs: This is its greatest advantage. Traditional methods require 2-3 days for results, while molecular testing only takes 1-2 hours. This is crucial for pregnant women who are admitted to the hospital near labor and have not undergone prenatal GBS screening. It allows for rapid determination of the need for antibiotic prophylaxis, enabling "on-call testing" and avoiding missed intervention opportunities.
2.Higher accuracy reduces missed detections: Group B Streptococcus Detection Kit uses PCR technology. Its exceptional sensitivity allows detection of trace amounts of the GBS pathogen, significantly reducing the risk of false-negative results and thus more effectively protecting newborns from infection.
3.Easy and automated operation reduces errors: The workflow is streamlined, reducing operator skill requirements. Results are automatically analyzed by the instrument, making them more standardized and reliable.
4.Improves patient management and clinical decision-making: The rapid turnaround time enables obstetricians to make prompt decisions on whether to administer antibiotics based on accurate results, avoiding empirical or overmedication in unscreened pregnant women and enabling more precise care.